Current management tactics for patients with dementia
Dementia develops as a result of continuous long-term progression of less severe cognitive impairment (CI). Social and psychological methods (neurocognitive stimulation and neurocognitive training) are the mainstay of treatment for dementia. At the moment, there are no drugs both to cure dementia an...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2018-06-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/893 |
| _version_ | 1827062818507063296 |
|---|---|
| author | A. V. Medvedeva O. V. Kosivtsova K. A. Makhinov |
| author_facet | A. V. Medvedeva O. V. Kosivtsova K. A. Makhinov |
| author_sort | A. V. Medvedeva |
| collection | DOAJ |
| description | Dementia develops as a result of continuous long-term progression of less severe cognitive impairment (CI). Social and psychological methods (neurocognitive stimulation and neurocognitive training) are the mainstay of treatment for dementia. At the moment, there are no drugs both to cure dementia and to stop the degeneration of nerve tissue. Modern pharmacotherapy for dementia aims to maintain cognitive functions in the patient for as long as possible and to slow down disability, thus ensuring higher living standards. CI therapy most often consists of compensation for cognitive defect. Among the whole variety of pharmacological agents, the effective drugs to treat dementia are only two groups, such as acetylcholinesterase inhibitors and N-methyl-D-aspartate (NMDA) glutamate receptor antagonists. Atypical neuroleptics are employed for the treatment of psychotic disorders; antidepressants from a group of selective serotonin reuptake inhibitors are for depression. Cognitive behavioral therapy and cognitive stimulation deserve special attention. A high educational level and physical, social, and intellectual and activities can prevent dementia. |
| first_indexed | 2024-04-10T02:01:31Z |
| format | Article |
| id | doaj.art-0069d81f28204b39a54962eb55951ec2 |
| institution | Directory Open Access Journal |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| last_indexed | 2025-02-18T20:01:56Z |
| publishDate | 2018-06-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj.art-0069d81f28204b39a54962eb55951ec22024-10-17T16:15:25ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422018-06-0110210210810.14412/2074-2711-2018-2-102-108738Current management tactics for patients with dementiaA. V. Medvedeva0O. V. Kosivtsova1K. A. Makhinov2I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaDementia develops as a result of continuous long-term progression of less severe cognitive impairment (CI). Social and psychological methods (neurocognitive stimulation and neurocognitive training) are the mainstay of treatment for dementia. At the moment, there are no drugs both to cure dementia and to stop the degeneration of nerve tissue. Modern pharmacotherapy for dementia aims to maintain cognitive functions in the patient for as long as possible and to slow down disability, thus ensuring higher living standards. CI therapy most often consists of compensation for cognitive defect. Among the whole variety of pharmacological agents, the effective drugs to treat dementia are only two groups, such as acetylcholinesterase inhibitors and N-methyl-D-aspartate (NMDA) glutamate receptor antagonists. Atypical neuroleptics are employed for the treatment of psychotic disorders; antidepressants from a group of selective serotonin reuptake inhibitors are for depression. Cognitive behavioral therapy and cognitive stimulation deserve special attention. A high educational level and physical, social, and intellectual and activities can prevent dementia.https://nnp.ima-press.net/nnp/article/view/893dementiaalzheimer's diseaseanticholinesterase drugsnmda receptor antagonists |
| spellingShingle | A. V. Medvedeva O. V. Kosivtsova K. A. Makhinov Current management tactics for patients with dementia Неврология, нейропсихиатрия, психосоматика dementia alzheimer's disease anticholinesterase drugs nmda receptor antagonists |
| title | Current management tactics for patients with dementia |
| title_full | Current management tactics for patients with dementia |
| title_fullStr | Current management tactics for patients with dementia |
| title_full_unstemmed | Current management tactics for patients with dementia |
| title_short | Current management tactics for patients with dementia |
| title_sort | current management tactics for patients with dementia |
| topic | dementia alzheimer's disease anticholinesterase drugs nmda receptor antagonists |
| url | https://nnp.ima-press.net/nnp/article/view/893 |
| work_keys_str_mv | AT avmedvedeva currentmanagementtacticsforpatientswithdementia AT ovkosivtsova currentmanagementtacticsforpatientswithdementia AT kamakhinov currentmanagementtacticsforpatientswithdementia |